Analytical Tool - Cancer Vaccines

  • ID: 1196672
  • March 2014
  • Region: Global
  • Bioseeker
1 of 2

"Analytical Tool - Cancer Vaccines" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer vaccine drug development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:

Cancer Vaccines: From First-in-Class to Best-in-Class?
Cancer Vaccines: Drug Pipeline Update 2014*

The Package Includes
- A progress analysis on current and emerging drugs
- Information on most companies active in cancer vaccine R&D
- Information on key industry READ MORE >

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. Updates are supplied for this report during the year. This is a single user license, allowing one specific user access to the product.


If you have a more general question about our products please try our



Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S